Jim Simons’s VIVEVE MED INC VIVE Stock Holding History

Jim Simons’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,000	Closed	-$14K	–	4576
2022 Q4	$14K	Sell	32,000 -400	-1%	-$202	﹤0.01%	4016
2022 Q3	$22K	Buy	32,400 +2,600	+9%	+$1.95K	﹤0.01%	3888
2022 Q2	$20K	Sell	29,800 -29,649	-50%	-$25.2K	﹤0.01%	4123
2022 Q1	$63K	Buy	59,449 +1,749	+3%	+$1.75K	﹤0.01%	3874
2021 Q4	$66K	Buy	+57,700	New	+$106K	﹤0.01%	3752
2020 Q2	–	Sell	-6,722	Closed	-$46K	–	3868
2020 Q1	$46K	Buy	+6,722	New	+$66.9K	﹤0.01%	3330

Other funds holding VIVE

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Jim Simons's VIVE Position: Q1 2023 in Review

Jim Simons sold out of VIVEVE MED INC (VIVE) in Q1 2023, closing a stake of 32,000 shares — an estimated $14K sold.

Jim Simons first reported a position in VIVE in Q1 2020 and held it in 6 quarters. The position peaked at $66K in Q4 2021. 1 fund tracked by Wall St. Rank holds VIVE as of Q1 2023.

Jim Simons reported no remaining VIVEVE MED INC position as of Q1 2023 after selling out during the quarter.
Jim Simons sold 32,000 VIVEVE MED INC shares in Q1 2023, an estimated $14K.
Jim Simons first reported a position in VIVEVE MED INC in Q1 2020 and held it in 6 quarters.
Jim Simons's VIVEVE MED INC position peaked at $66K in Q4 2021.
1 fund tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.